. 2020 May 18;9(6):519–529. doi: 10.1530/EC-20-0196
This work is licensed under a Table 2.
Stages and pathologic findings.
| Available | n (%) | Median (IQR) | |
|---|---|---|---|
| ENSAT stage | 174 | ||
| 1 | 19 (9.3) | ||
| 2 | 62 (30.4) | ||
| 3 | 35 (17.2) | ||
| 4 | 58 (28.4) | ||
| Unknown | 30 | 30 (14.7) | |
| Pathology | |||
| Weiss score | 61 | ||
| ≤3 | 21 (34.4) | ||
| >3 | 40 (65.6) | ||
| Size (mm) | 147 | 100 (64–130) | |
| Ki-67 index | 30 | 8 (4.5–16.3) | |
| Mitotic count (/50HPF) | 100 | 10 (5–28.8) | |
| High nuclear grade (yes) | 67 | 62 (92.5) | |
| Atypical mitosis (yes) | 72 | 26 (36.1) | |
| Diffuse architecture (yes) | 47 | 39 (83.0) | |
| Clear cell component (yes) | 63 | 47 (74.6) | |
| Necrosis (yes) | 137 | 122 (89.1) | |
| Venous invasion (yes) | 107 | 52 (48.61) | |
| Sinusoidal invasion (yes) | 60 | 23 (38.3) | |
| Capsular invasion (yes) | 123 | 80 (65) |
ENSAT, European Network for Study of Adrenal Tumors; IQR, interquartile range.